Clinical Guideline

0 Comments

10 August 2017

Joint Statement on clinical selection for Trans-catheter Aortic Valve Implantation

Guidelines for clinical selection of TAVI patients

A joint statement from BCIS, BCS and Society for Cardiothoracic Surgery

Previous | Next

Summary

Joint Statement on clinical selection for Trans-catheter Aortic Valve Implantation (TAVI)

Intervention for aortic stenosis is evolving rapidly. Trans-catheter aortic valve implantation is a minimally invasive alternative to surgical aortic valve replacement. The evidence base for use of TAVI as an alternative to either medical therapy or SAVR has expanded. This statement summarises the views of the British Cardiovascular Society, Society for Cardiothoracic Surgery, and the British Cardiovascular Intervention Society on how patients with aortic valve disease should be treated and which patients are best suited to TAVI, on the basis of current evidence.

Summary

Joint Statement on clinical selection for Trans-catheter Aortic Valve Implantation (TAVI)

Intervention for aortic stenosis is evolving rapidly. Trans-catheter aortic valve implantation is a minimally invasive alternative to surgical aortic valve replacement. The evidence base for use of TAVI as an alternative to either medical therapy or SAVR has expanded. This statement summarises the views of the British Cardiovascular Society, Society for Cardiothoracic Surgery, and the British Cardiovascular Intervention Society on how patients with aortic valve disease should be treated and which patients are best suited to TAVI, on the basis of current evidence.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In